Fibin Knockout C2C12 Cell Line
Cat.No.:
EDJ-KQ78169
Species:
Mouse
Cell Name:
C2C12
Gene:
Fibin
Gene ID:
67606
Size:
1×10⁶cells
Fibin Knockout Cell Line (C2C12) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDJ-KQ78169 |
|---|---|
| Product Name | Fibin Knockout Cell Line (C2C12) |
| Cell line | C2C12 |
| Cellosaurus ID | CVCL_0188 |
| Cell Line Synonyms | C2c12, C2-C12, C12 |
| Gene |
Fibin
|
| NCBI Gene ID | |
| Morphology | Adherent |
| Passage Ratio | 1/4-1/3,2 days |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 95% Complete culture medium + 5% DMSO(ATCC) |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: C2C12 | STR Info (Cell bank) Cell Line: C2C12 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| 1-1 | 10 | |||
| 1-2 | 16 | |||
| 2-1 | 9 | |||
| 3-2 | 14 | |||
| 4-2 | 19.3 | 19.3 | ||
| 5-5 | 15 | 15 | ||
| 6-4 | 18 | 18 | ||
| 6-7 | 12 | 12 | ||
| 7-1 | 26 | |||
| 8-1 | 17 | |||
| 11-2 | 16 | |||
| 12-1 | 16 | 16 | ||
| 13-1 | 17.1 | |||
| 15-3 | 25.3 | 25.3 | ||
| 17-2 | 15 | |||
| 18-3 | 16 | 16 | ||
| 19-2 | 12 | |||
| X-1 | 25 | 26 | 25 | 26 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Is this fibin Knockout C2C12 Cell Line compatible with overexpression rescue experiments?
Yes. Key considerations for rescue experiments in this model:
• Construct design: use a codon-modified or 3' UTR-truncated Fibin sequence to avoid re-targeting by the original guide RNA. An N- or C-terminal tag (FLAG, HA) allows unambiguous detection of exogenous protein.
• Delivery method: stable lentiviral or PiggyBac integration is preferable for differentiation assays that run over multiple days; transient transfection introduces expression variability that complicates fusion index quantification.
• Differentiation timing: the choice of whether to express Fibin in proliferating myoblasts versus during differentiation matters — Fibin may have stage-specific functions. Inducible (Tet-On) systems allow temporal control and are recommended where the relevant stage is unclear.
• Functional validation: rescue should restore the knockout phenotype (fusion index, marker expression). For an emerging factor like Fibin, including a control rescue with an unrelated protein helps rule out non-specific effects of viral integration on differentiation.
C2C12 cells tolerate lentiviral transduction and antibiotic selection without significant loss of differentiation capacity, making this line well-suited for generating stable rescue sublines.
Which is better for studying fibin function, fibin Knockout C2C12 Cell Line or fibin overexpression C2C12 Cell Line?
Neither model is inherently better — the right choice depends on the experimental question. The Knockout line is appropriate when asking whether Fibin is required for a process such as myogenic differentiation, regeneration response, or developmental program execution. Overexpression is appropriate when asking whether forced Fibin expression is sufficient to drive or enhance these processes — useful given Fibin's relatively low baseline expression in undifferentiated C2C12.
For researchers entering Fibin biology, the EDITGENE Knockout line is the more conservative starting point: loss-of-function phenotypes are easier to interpret for emerging factors where reference data is still being established. The strongest experimental design combines both — a Knockout phenotype rescued by Fibin re-introduction substantially strengthens the conclusion that the phenotype is Fibin-specific rather than off-target editing.
What are the application scenarios for this model?
Primary applications:
• Differentiation phenotyping: time-course assays (24–96h post-induction) with fusion index quantification and myotube morphology scoring to assess Fibin's contribution to C2C12 differentiation capacity.
• Myogenic marker profiling: Western blot or immunofluorescence for MyoD, Myogenin, MRF4, and MyHC across differentiation stages to localize which phase of the program is affected.
• Transcriptomic analysis: RNA-seq at matched differentiation stages to identify transcriptional changes associated with Fibin loss; results are hypothesis-generating and require targeted follow-up validation.
• Regeneration pathway studies: Notch, Wnt, and IGF pathway activity assays in the knockout background.
EDITGENE recommends confirming protein-level knockout by Western blot before proceeding to downstream assays.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.